These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 16921542)
21. [Synthesis and pharmacologic study of new esters of naproxen with derivatives of N-oxyethylpiperazine]. Calvi E; Picciòla G; Carenini G; Gentili P Farmaco Sci; 1985 May; 40(5):334-46. PubMed ID: 3874093 [TBL] [Abstract][Full Text] [Related]
23. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Ranpise NS; Kulkarni NS; Mair PD; Ranade AN Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225 [TBL] [Abstract][Full Text] [Related]
24. Convenient synthesis of Ibuprofen and naproxen aminoacyl, dipeptidoyl and ester derivatives. Katritzky AR; Jishkariani D; Narindoshvili T Chem Biol Drug Des; 2009 Jun; 73(6):618-26. PubMed ID: 19635053 [TBL] [Abstract][Full Text] [Related]
25. Meloxicam complexation with beta-cyclodextrin: influence on the anti-inflammatory and ulcerogenic activity. Baboota S; Agarwal SP Pharmazie; 2003 Jan; 58(1):73-4. PubMed ID: 12622261 [No Abstract] [Full Text] [Related]
35. Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives of naproxen. Amir M; Kumar H; Javed SA Bioorg Med Chem Lett; 2007 Aug; 17(16):4504-8. PubMed ID: 17576062 [TBL] [Abstract][Full Text] [Related]
36. Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors. Kolasa T; Brooks CD; Rodriques KE; Summers JB; Dellaria JF; Hulkower KI; Bouska J; Bell RL; Carter GW J Med Chem; 1997 Feb; 40(5):819-24. PubMed ID: 9057869 [TBL] [Abstract][Full Text] [Related]
37. NO-donors (VII [1]): synthesis and cyclooxygenase inhibitory properties of N-and S-nitrooxypivaloyl-cysteine derivatives of naproxen -- a novel type of NO-NSAID. Kartasasmita RE; Laufer S; Lehmann J Arch Pharm (Weinheim); 2002 Aug; 335(8):363-6. PubMed ID: 12397619 [TBL] [Abstract][Full Text] [Related]
38. Influence of water soluble polymers on hydroxypropyl-beta-cyclodextrin complexation of rofecoxib. Singh I; Aboul-Enein HY Pharmazie; 2007 Apr; 62(4):284-6. PubMed ID: 17484284 [TBL] [Abstract][Full Text] [Related]
39. Synergistic effect of the interaction between naproxen and citral on inflammation in rats. Ortiz MI; González-García MP; Ponce-Monter HA; Castañeda-Hernández G; Aguilar-Robles P Phytomedicine; 2010 Dec; 18(1):74-9. PubMed ID: 20637575 [TBL] [Abstract][Full Text] [Related]
40. Preparation and properties of valdecoxib-hydroxypropyl beta-cyclodextrin inclusion complex. Gowrishankar P; Ali M; Baboota S PDA J Pharm Sci Technol; 2007; 61(3):175-82. PubMed ID: 17722484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]